schliessen

Filtern

 

Bibliotheken

Tea beverage in chemoprevention and chemotherapy of prostate cancer

Prostate cancer (PCa) is the most frequently diagnosed malignancy and the second leading cause of cancer-related deaths in American males with similar trends in many western countries. The existing treatment approaches and surgical intervention have not been able to effectively cope with this dreade... Full description

Journal Title: Acta pharmacologica Sinica 2007, Vol.28 (9), p.1392-1408
Main Author: SIDDIQUI, Imtiaz A
Other Authors: SALEEM, Mohammad , ADHAMI, Vaqar M , ASIM, Mohammad , MUKHTAR, Hasan
Format: Electronic Article Electronic Article
Language: English
Subjects:
PSA
Tea
Publisher: United States: Blackwell Publishing
ID: ISSN: 1671-4083
Link: https://www.ncbi.nlm.nih.gov/pubmed/17723173
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_68207492
title: Tea beverage in chemoprevention and chemotherapy of prostate cancer
format: Article
creator:
  • SIDDIQUI, Imtiaz A
  • SALEEM, Mohammad
  • ADHAMI, Vaqar M
  • ASIM, Mohammad
  • MUKHTAR, Hasan
subjects:
  • (-) epicatechin
  • (-)epigallocatechin-3-gallate
  • androgen receptor
  • Animals
  • Anticarcinogenic Agents - chemistry
  • Anticarcinogenic Agents - therapeutic use
  • apoptosis
  • Cancer
  • Chemotherapy
  • clinical studies
  • Clinical Trials as Topic
  • epidemiology
  • Flavonoids - chemistry
  • Flavonoids - therapeutic use
  • Green tea
  • Humans
  • Male
  • Phenols - chemistry
  • Phenols - therapeutic use
  • Polyphenols
  • Prevention
  • Prostate cancer
  • Prostate-Specific Antigen - metabolism
  • Prostatic Neoplasms - epidemiology
  • Prostatic Neoplasms - prevention & control
  • PSA
  • Tea
  • Tea - chemistry
  • tumor xenograft
ispartof: Acta pharmacologica Sinica, 2007, Vol.28 (9), p.1392-1408
description: Prostate cancer (PCa) is the most frequently diagnosed malignancy and the second leading cause of cancer-related deaths in American males with similar trends in many western countries. The existing treatment approaches and surgical intervention have not been able to effectively cope with this dreaded disease. For these reasons, it is necessary to intensify our efforts for a better understanding of the disease process and for the development of novel approaches for its prevention and treatment. Based on considerable evidence from in vivo and in vitro data and epidemiological studies, in recent years the beverage tea has gained considerable attention for reducing the risk of several cancers. Much of the cancer preventive effects of tea, especially green tea appear to be mediated by the polyphenols present therein. Geographical evidence suggests that the incidence and occurrence of PCa is lower in populations that consume tea regularly. This evidence suggests that tea polyphenols could be extrapolated to optimize their chemopreventive properties against PCa. PCa represents an excellent candidate disease for chemoprevention because it is typically diagnosed in men over 50 years of age and therefore, even a modest delay in neoplastic development achieved through pharmacological or nutritional intervention could result in a substantial reduction in the incidence of clinically detectable disease. In this review we address the issue of possible use of tea, especially green tea, for the prevention as well as treatment of PCa.
language: eng
source:
identifier: ISSN: 1671-4083
fulltext: no_fulltext
issn:
  • 1671-4083
  • 1745-7254
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.174105
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_68207492
sourceformatXML
sourcesystemPC
ingidbsc/aphs/2007/00000028/00000009/art00013
galeidA168311609
sourcerecordidA168311609
originalsourceidFETCH-LOGICAL-1537t-cc0114aef8aa80022ec42c50cf4461475e94415aab87611a73c236691212bb0b0
addsrcrecordideNqNksFu1DAQhiMEomXhFVAEErcEj-3EyQVptaIFqRKXcrYmXmfXq8QJdoLat--ELEVUHLAPHk2--Wc0f5IkBZYDnY-nHJQsMsULmXPGVM5YWYv87lly-fjhOcWlgkyySlwkr2I8MSa4gPplcgFKUaTEZbK7tZg29qcNeLCp86k52n4YA2X85Aafot-vuelIzHifDm06hiFOONnUoDc2vE5etNhF--b8bpLvV59vd1-ym2_XX3fbmwwKoabMGAYg0bYVYsUY59ZIbgpmWilLkKqwtZRQIDaVKgFQCcNFWdbAgTcNa9gm-bDqUv8fs42T7l00tuvQ22GOuqw4U7LmBL57Ap6GOXiaTXMQjLOC7iZ5v0IH7Kx2vh2mgGZR1FsoKwFQspqo_B8U3b3tnRm8bR3l_yqo1gJDS4rBtnoMrsdwr4HpxTx90otHevFIL-bpX-bpOyp9ex57bnq7_1N4douAT0-0jSMfyCYaynX_0yFdBTxOc7CPHXCMCwdq2d12RZw_0C-AOvbYdTRR1A2tBsdj_K25HF6dA1ZrDBO9tOAHnUXFdw
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid213020505
display
typearticle
titleTea beverage in chemoprevention and chemotherapy of prostate cancer
creatorSIDDIQUI, Imtiaz A ; SALEEM, Mohammad ; ADHAMI, Vaqar M ; ASIM, Mohammad ; MUKHTAR, Hasan
creatorcontribSIDDIQUI, Imtiaz A ; SALEEM, Mohammad ; ADHAMI, Vaqar M ; ASIM, Mohammad ; MUKHTAR, Hasan
descriptionProstate cancer (PCa) is the most frequently diagnosed malignancy and the second leading cause of cancer-related deaths in American males with similar trends in many western countries. The existing treatment approaches and surgical intervention have not been able to effectively cope with this dreaded disease. For these reasons, it is necessary to intensify our efforts for a better understanding of the disease process and for the development of novel approaches for its prevention and treatment. Based on considerable evidence from in vivo and in vitro data and epidemiological studies, in recent years the beverage tea has gained considerable attention for reducing the risk of several cancers. Much of the cancer preventive effects of tea, especially green tea appear to be mediated by the polyphenols present therein. Geographical evidence suggests that the incidence and occurrence of PCa is lower in populations that consume tea regularly. This evidence suggests that tea polyphenols could be extrapolated to optimize their chemopreventive properties against PCa. PCa represents an excellent candidate disease for chemoprevention because it is typically diagnosed in men over 50 years of age and therefore, even a modest delay in neoplastic development achieved through pharmacological or nutritional intervention could result in a substantial reduction in the incidence of clinically detectable disease. In this review we address the issue of possible use of tea, especially green tea, for the prevention as well as treatment of PCa.
identifier
0ISSN: 1671-4083
1EISSN: 1745-7254
2DOI: 10.1111/j.1745-7254.2007.00693.x
3PMID: 17723173
languageeng
publisherUnited States: Blackwell Publishing
subject(-) epicatechin ; (-)epigallocatechin-3-gallate ; androgen receptor ; Animals ; Anticarcinogenic Agents - chemistry ; Anticarcinogenic Agents - therapeutic use ; apoptosis ; Cancer ; Chemotherapy ; clinical studies ; Clinical Trials as Topic ; epidemiology ; Flavonoids - chemistry ; Flavonoids - therapeutic use ; Green tea ; Humans ; Male ; Phenols - chemistry ; Phenols - therapeutic use ; Polyphenols ; Prevention ; Prostate cancer ; Prostate-Specific Antigen - metabolism ; Prostatic Neoplasms - epidemiology ; Prostatic Neoplasms - prevention & control ; PSA ; Tea ; Tea - chemistry ; tumor xenograft
ispartofActa pharmacologica Sinica, 2007, Vol.28 (9), p.1392-1408
rights
0COPYRIGHT 2007 Blackwell Publishers Ltd.
1Copyright Nature Publishing Group Sep 2007
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-1537t-cc0114aef8aa80022ec42c50cf4461475e94415aab87611a73c236691212bb0b0
citesFETCH-LOGICAL-1537t-cc0114aef8aa80022ec42c50cf4461475e94415aab87611a73c236691212bb0b0
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17723173$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0SIDDIQUI, Imtiaz A
1SALEEM, Mohammad
2ADHAMI, Vaqar M
3ASIM, Mohammad
4MUKHTAR, Hasan
title
0Tea beverage in chemoprevention and chemotherapy of prostate cancer
1Acta pharmacologica Sinica
addtitleActa Pharmacol Sin
descriptionProstate cancer (PCa) is the most frequently diagnosed malignancy and the second leading cause of cancer-related deaths in American males with similar trends in many western countries. The existing treatment approaches and surgical intervention have not been able to effectively cope with this dreaded disease. For these reasons, it is necessary to intensify our efforts for a better understanding of the disease process and for the development of novel approaches for its prevention and treatment. Based on considerable evidence from in vivo and in vitro data and epidemiological studies, in recent years the beverage tea has gained considerable attention for reducing the risk of several cancers. Much of the cancer preventive effects of tea, especially green tea appear to be mediated by the polyphenols present therein. Geographical evidence suggests that the incidence and occurrence of PCa is lower in populations that consume tea regularly. This evidence suggests that tea polyphenols could be extrapolated to optimize their chemopreventive properties against PCa. PCa represents an excellent candidate disease for chemoprevention because it is typically diagnosed in men over 50 years of age and therefore, even a modest delay in neoplastic development achieved through pharmacological or nutritional intervention could result in a substantial reduction in the incidence of clinically detectable disease. In this review we address the issue of possible use of tea, especially green tea, for the prevention as well as treatment of PCa.
subject
0(-) epicatechin
1(-)epigallocatechin-3-gallate
2androgen receptor
3Animals
4Anticarcinogenic Agents - chemistry
5Anticarcinogenic Agents - therapeutic use
6apoptosis
7Cancer
8Chemotherapy
9clinical studies
10Clinical Trials as Topic
11epidemiology
12Flavonoids - chemistry
13Flavonoids - therapeutic use
14Green tea
15Humans
16Male
17Phenols - chemistry
18Phenols - therapeutic use
19Polyphenols
20Prevention
21Prostate cancer
22Prostate-Specific Antigen - metabolism
23Prostatic Neoplasms - epidemiology
24Prostatic Neoplasms - prevention & control
25PSA
26Tea
27Tea - chemistry
28tumor xenograft
issn
01671-4083
11745-7254
fulltextfalse
rsrctypearticle
creationdate2007
recordtypearticle
recordideNqNksFu1DAQhiMEomXhFVAEErcEj-3EyQVptaIFqRKXcrYmXmfXq8QJdoLat--ELEVUHLAPHk2--Wc0f5IkBZYDnY-nHJQsMsULmXPGVM5YWYv87lly-fjhOcWlgkyySlwkr2I8MSa4gPplcgFKUaTEZbK7tZg29qcNeLCp86k52n4YA2X85Aafot-vuelIzHifDm06hiFOONnUoDc2vE5etNhF--b8bpLvV59vd1-ym2_XX3fbmwwKoabMGAYg0bYVYsUY59ZIbgpmWilLkKqwtZRQIDaVKgFQCcNFWdbAgTcNa9gm-bDqUv8fs42T7l00tuvQ22GOuqw4U7LmBL57Ap6GOXiaTXMQjLOC7iZ5v0IH7Kx2vh2mgGZR1FsoKwFQspqo_B8U3b3tnRm8bR3l_yqo1gJDS4rBtnoMrsdwr4HpxTx90otHevFIL-bpX-bpOyp9ex57bnq7_1N4douAT0-0jSMfyCYaynX_0yFdBTxOc7CPHXCMCwdq2d12RZw_0C-AOvbYdTRR1A2tBsdj_K25HF6dA1ZrDBO9tOAHnUXFdw
startdate200709
enddate200709
creator
0SIDDIQUI, Imtiaz A
1SALEEM, Mohammad
2ADHAMI, Vaqar M
3ASIM, Mohammad
4MUKHTAR, Hasan
general
0Blackwell Publishing
1Wiley Subscription Services, Inc
2Nature Publishing Group
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
93V.
107QP
117QR
127T5
137TK
147TO
157U9
167X7
177XB
1888E
198FD
208FE
218FH
228FI
238FJ
248FK
25ABUWG
26AZQEC
27BBNVY
28BENPR
29BHPHI
30DWQXO
31FR3
32FYUFA
33GHDGH
34GNUQQ
35H94
36HCIFZ
37K9.
38LK8
39M0S
40M1P
41M7N
42M7P
43P64
44PQEST
45PQQKQ
46PQUKI
47PRINS
487X8
sort
creationdate200709
titleTea beverage in chemoprevention and chemotherapy of prostate cancer
authorSIDDIQUI, Imtiaz A ; SALEEM, Mohammad ; ADHAMI, Vaqar M ; ASIM, Mohammad ; MUKHTAR, Hasan
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1537t-cc0114aef8aa80022ec42c50cf4461475e94415aab87611a73c236691212bb0b0
rsrctypearticles
prefilterarticles
languageeng
creationdate2007
topic
0(-) epicatechin
1(-)epigallocatechin-3-gallate
2androgen receptor
3Animals
4Anticarcinogenic Agents - chemistry
5Anticarcinogenic Agents - therapeutic use
6apoptosis
7Cancer
8Chemotherapy
9clinical studies
10Clinical Trials as Topic
11epidemiology
12Flavonoids - chemistry
13Flavonoids - therapeutic use
14Green tea
15Humans
16Male
17Phenols - chemistry
18Phenols - therapeutic use
19Polyphenols
20Prevention
21Prostate cancer
22Prostate-Specific Antigen - metabolism
23Prostatic Neoplasms - epidemiology
24Prostatic Neoplasms - prevention & control
25PSA
26Tea
27Tea - chemistry
28tumor xenograft
toplevelpeer_reviewed
creatorcontrib
0SIDDIQUI, Imtiaz A
1SALEEM, Mohammad
2ADHAMI, Vaqar M
3ASIM, Mohammad
4MUKHTAR, Hasan
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8ProQuest Central (Corporate)
9Calcium & Calcified Tissue Abstracts
10Chemoreception Abstracts
11Immunology Abstracts
12Neurosciences Abstracts
13Oncogenes and Growth Factors Abstracts
14Virology and AIDS Abstracts
15Health & Medical Collection
16ProQuest Central (purchase pre-March 2016)
17Medical Database (Alumni Edition)
18Technology Research Database
19ProQuest SciTech Collection
20ProQuest Natural Science Collection
21Hospital Premium Collection
22Hospital Premium Collection (Alumni Edition)
23ProQuest Central (Alumni) (purchase pre-March 2016)
24ProQuest Central (Alumni Edition)
25ProQuest Central Essentials
26Biological Science Collection
27ProQuest Central
28Natural Science Collection
29ProQuest Central Korea
30Engineering Research Database
31Health Research Premium Collection
32Health Research Premium Collection (Alumni)
33ProQuest Central Student
34AIDS and Cancer Research Abstracts
35SciTech Premium Collection
36ProQuest Health & Medical Complete (Alumni)
37ProQuest Biological Science Collection
38Health & Medical Collection (Alumni Edition)
39Medical Database
40Algology Mycology and Protozoology Abstracts (Microbiology C)
41Biological Science Database
42Biotechnology and BioEngineering Abstracts
43ProQuest One Academic Eastern Edition
44ProQuest One Academic
45ProQuest One Academic UKI Edition
46ProQuest Central China
47MEDLINE - Academic
jtitleActa pharmacologica Sinica
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0SIDDIQUI, Imtiaz A
1SALEEM, Mohammad
2ADHAMI, Vaqar M
3ASIM, Mohammad
4MUKHTAR, Hasan
formatjournal
genrearticle
ristypeJOUR
atitleTea beverage in chemoprevention and chemotherapy of prostate cancer
jtitleActa pharmacologica Sinica
addtitleActa Pharmacol Sin
date2007-09
risdate2007
volume28
issue9
spage1392
epage1408
pages1392-1408
issn1671-4083
eissn1745-7254
abstractProstate cancer (PCa) is the most frequently diagnosed malignancy and the second leading cause of cancer-related deaths in American males with similar trends in many western countries. The existing treatment approaches and surgical intervention have not been able to effectively cope with this dreaded disease. For these reasons, it is necessary to intensify our efforts for a better understanding of the disease process and for the development of novel approaches for its prevention and treatment. Based on considerable evidence from in vivo and in vitro data and epidemiological studies, in recent years the beverage tea has gained considerable attention for reducing the risk of several cancers. Much of the cancer preventive effects of tea, especially green tea appear to be mediated by the polyphenols present therein. Geographical evidence suggests that the incidence and occurrence of PCa is lower in populations that consume tea regularly. This evidence suggests that tea polyphenols could be extrapolated to optimize their chemopreventive properties against PCa. PCa represents an excellent candidate disease for chemoprevention because it is typically diagnosed in men over 50 years of age and therefore, even a modest delay in neoplastic development achieved through pharmacological or nutritional intervention could result in a substantial reduction in the incidence of clinically detectable disease. In this review we address the issue of possible use of tea, especially green tea, for the prevention as well as treatment of PCa.
copUnited States
pubBlackwell Publishing
pmid17723173
doi10.1111/j.1745-7254.2007.00693.x
oafree_for_read